"Mitral regurgitation and Tricuspid regurgitation are clinical conditions, needing Solutions."
This problem affects millions of people worldwide.
NCSI has developed potential solutions for both interventionalists and surgeons to treat Mitral regurgitation and Tricuspid regurgitation.
Have begun 15-30 patient Trans-Atrial feasibility trial to obtain preliminary Safety & Efficacy data for the Mitral valved stent
NCSI valves are offered in 3 sizes for each application to capture the range of dilated mitral valve annulus or tricuspid valve annulus.